12/17/2025
As we close out the year, we’re proud of the progress Cytovale has made toward our goal: delivering earlier, objective sepsis risk insights that help clinicians act faster and help more patients survive.
2025 highlights:
➡️ Published real-world evidence from a 12,000+ patient study
➡️ 500+ physicians now using IntelliSep in practice
➡️ 60,000+ patients tested with IntelliSep
➡️ Connected with hundreds of hospital executives, physician leaders, and patients at conferences and events
➡️ Built strong momentum with partners, supporting system expansion and broader access
What’s next for Cytovale:
➡️ Generating new evidence to deepen clinical impact
➡️ Strengthening existing partnerships
➡️ Building new partnerships to expand access nationwide
To the frontline clinicians caring for patients every day, our hospital partners who collaborate with us, and the Cytovale team pushing this mission forward, thank you. Your commitment is what makes this progress possible.